Dexmedetomidine Hydrochloride Injection, Solution
Product Images NDC 71872-7122

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine Hydrochloride (NDC 71872-7122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7122)

This text describes the medication information for Dexmedetomidine Hydrochloride Injection. The medication comes in a single-dose vial that needs to be diluted before use. The solution is for intravenous infusion and contains sodium chloride in water for injection, with a pH of 4.5 to 7.0. The usual dosage instructions are provided in the insert. The medication should be stored at a temperature range of 20°C to 25°C. The manufacturer is Gland Pharma Limited, while the distributor is Sun Pharmaceutical Industries, Inc. The text also includes details on the lot and expiration date of the product.*

FDA Label Image

Structure (Dexmedetomidine 1)

FDA Label Image

Principal Display Panel-label (Dexmedetomidine 2)

This is a description of a 2mL single dose vial containing Dexmedetomidine Hydrochloride Injection. The vial has an NDC code of 57664-596-40 and contains 200 mcg/2 mL (100 meg/mL) of Dexmedetomidine. It is for intravenous infusion and must be diluted before use. The unused portion should be discarded. The vial is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ and manufactured by Gland Pharma Limited in Hyderabad, India. The vial has an expiration date, but it is not available in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.